JACI: In Practice Response to COVID-19 Pandemic

Dawn M. Angel; Robert S. Zeiger; Scott H. Sicherer; David A. Khan; Michael Schatz

doi:10.1016/j.jaip.2020.03.027

JACI: In Practice Response to COVID-19 Pandemic

Dawn M. Angel, Robert S. Zeiger, Scott H. Sicherer, David A. Khan, Michael Schatz

Research output: Contribution to journal › Editorial

2 Scopus citations

Original language	English
Pages (from-to)	1475-1476
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	8
Issue number	5
DOIs	https://doi.org/10.1016/j.jaip.2020.03.027
State	Published - May 2020

Access to Document

10.1016/j.jaip.2020.03.027

Cite this

@article{ac505bd3c48a42d69369beea74d8c272,

title = "JACI: In Practice Response to COVID-19 Pandemic",

author = "Angel, {Dawn M.} and Zeiger, {Robert S.} and Sicherer, {Scott H.} and Khan, {David A.} and Michael Schatz",

note = "Funding Information: Conflicts of interest: D. M. Angel is Managing Editor of the Journal of Allergy and Clinical Immunology: In Practice. R. S. Zeiger reports grants from the National Institutes of Health, ALK Pharma, Genentech, MedImmune/AstraZeneca, Merck & Co., and Teva to Kaiser Permanente Southern California; personal fees from the American Academy of Allergy, Asthma & Immunology as Deputy Editor of the Journal of Allergy and Clinical Immunology: In Practice, American College of Allergy, Asthma & Immunology, AstraZeneca, DBV Technologies, Genentech, Novartis, GlaxoSmithKline, and Regeneron Pharmaceuticals; and royalty payments from UpToDate. S. H. Sicherer reports royalty payments from UpToDate and from Johns Hopkins University Press; grants to his institution from the National Institute of Allergy and Infectious Diseases, from Food Allergy Research and Education, and from HAL Allergy; and personal fees from the American Academy of Allergy, Asthma & Immunology as Deputy Editor of the Journal of Allergy and Clinical Immunology: In Practice, outside of the submitted work. D. A. Khan is Associate Editor of the Journal of Allergy and Clinical Immunology: In Practice. M. Schatz is Editor-in-Chief of the Journal of Allergy and Clinical Immunology: In Practice and receives royalty payments from UpToDate and research grants to his institution from ALK, Merck, and Teva Pharmaceuticals.",

year = "2020",

month = may,

doi = "10.1016/j.jaip.2020.03.027",

language = "English",

volume = "8",

pages = "1475--1476",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - JACI

T2 - In Practice Response to COVID-19 Pandemic

AU - Angel, Dawn M.

AU - Zeiger, Robert S.

AU - Sicherer, Scott H.

AU - Khan, David A.

AU - Schatz, Michael

N1 - Funding Information: Conflicts of interest: D. M. Angel is Managing Editor of the Journal of Allergy and Clinical Immunology: In Practice. R. S. Zeiger reports grants from the National Institutes of Health, ALK Pharma, Genentech, MedImmune/AstraZeneca, Merck & Co., and Teva to Kaiser Permanente Southern California; personal fees from the American Academy of Allergy, Asthma & Immunology as Deputy Editor of the Journal of Allergy and Clinical Immunology: In Practice, American College of Allergy, Asthma & Immunology, AstraZeneca, DBV Technologies, Genentech, Novartis, GlaxoSmithKline, and Regeneron Pharmaceuticals; and royalty payments from UpToDate. S. H. Sicherer reports royalty payments from UpToDate and from Johns Hopkins University Press; grants to his institution from the National Institute of Allergy and Infectious Diseases, from Food Allergy Research and Education, and from HAL Allergy; and personal fees from the American Academy of Allergy, Asthma & Immunology as Deputy Editor of the Journal of Allergy and Clinical Immunology: In Practice, outside of the submitted work. D. A. Khan is Associate Editor of the Journal of Allergy and Clinical Immunology: In Practice. M. Schatz is Editor-in-Chief of the Journal of Allergy and Clinical Immunology: In Practice and receives royalty payments from UpToDate and research grants to his institution from ALK, Merck, and Teva Pharmaceuticals.

PY - 2020/5

Y1 - 2020/5

UR - http://www.scopus.com/inward/record.url?scp=85083793944&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2020.03.027

DO - 10.1016/j.jaip.2020.03.027

M3 - Editorial

C2 - 32272283

AN - SCOPUS:85083793944

SN - 2213-2198

VL - 8

SP - 1475

EP - 1476

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 5

ER -